| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Is Madrigal Pharmaceuticals Stock a Buy? | 4 | The Motley Fool | ||
| 08.05. | Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2024 Earnings Call Transcript | 13 | Insider Monkey | ||
| 07.05. | Madrigal Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 8 | Reuters | ||
| 07.05. | MADRIGAL PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| 07.05. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 24.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Statement on the Passing of Dr. Stephen Harrison | 25 | GlobeNewswire (USA) | ||
| 16.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 175 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH)... ► Artikel lesen | |
| 05.04. | Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics | 37 | The Motley Fool | ||
| 03.04. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 80 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., April 03, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis... ► Artikel lesen | |
| 02.04. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 8 | SEC Filings | ||
| 29.03. | Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals | 34 | The Motley Fool | ||
| 26.03. | Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock | 24 | The Motley Fool | ||
| 25.03. | Baker Bros. Advisors LP acquires Madrigal Pharmaceuticals warrants worth $105 | 13 | Investing.com | ||
| 20.03. | MADRIGAL PHARMACEUTICALS, INC. - 8-K, Current Report | 19 | SEC Filings | ||
| 19.03. | US STOCKS National Cinemedia, Madrigal Pharmaceuticals, dLocal | 4 | Reuters | ||
| 19.03. | Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win? | 22 | The Motley Fool | ||
| 19.03. | Madrigal Pharmaceuticals upsizes public offering to $600 million | 2 | Investing.com | ||
| 19.03. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering | 12 | GlobeNewswire (USA) | ||
| 18.03. | Madrigal Pharmaceuticals commences underwritten public offering | 2 | Seeking Alpha | ||
| 18.03. | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Proposed Public Offering | 7 | GlobeNewswire (USA) |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 6.881 |
| NEL | 4.269 |
| EVOTEC | 3.318 |
| TUI | 1.936 |
| PLUG POWER | 1.720 |
| BAYER | 1.541 |
| SUPER MICRO COMPUTER | 1.466 |
| BIONTECH | 1.402 |
| GAMESTOP | 1.340 |
| RHEINMETALL | 1.162 |
| VOLKSWAGEN | 910 |
| AIXTRON SE | 880 |
| DEUTSCHE BANK | 856 |
| DEUTSCHE LUFTHANSA | 836 |
| SIEMENS ENERGY | 828 |
| BYD | 812 |
| JINKOSOLAR | 807 |
| TESLA | 753 |
| COMMERZBANK | 738 |
| MERCEDES-BENZ | 725 |
| RENK GROUP | 706 |
| THYSSENKRUPP | 688 |
| INFINEON | 678 |
| CUREVAC | 660 |
| BASF | 609 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
